Q1 2024 · 13F-HR
Lion Point Capital, LPholdings as filed
Filed 2024-05-15 · accession 0001013594-24-000479
$179.0M
Reported value
32
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 816850101 | SMTC | SEMTECH CORP | $68.7M | 38.4% | 2,500,000 | CALL | SOLE |
| 464287655 | IWM | ISHARES TR | $52.0M | 29.1% | 247,500 | PUT | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $19.2M | 10.7% | 2,119,136 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $7.6M | 4.27% | 1,046,667 | Common | SOLE |
| 78464A870 | XBI | SPDR SER TR | $4.7M | 2.65% | 50,000 | PUT | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $4.1M | 2.30% | 2,300,207 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $2.6M | 1.44% | 130,691 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $2.0M | 1.11% | 600,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $1.9M | 1.07% | 70,335 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $1.9M | 1.06% | 170,000 | Common | SOLE |
| 12122L101 | 0LS | BURGERFI INTERNATIONAL INC | $1.6M | 0.89% | 2,745,938 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $1.5M | 0.86% | 65,000 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $1.4M | 0.78% | 82,500 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $1.1M | 0.63% | 45,000 | PUT | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $1.1M | 0.61% | 848,256 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $1.0M | 0.58% | 7,500 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $939,520 | 0.53% | 32,000 | Common | SOLE |
| G3167L109 | — | ENPHYS ACQUISITION CORP | $845,313 | 0.47% | 78,125 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $774,600 | 0.43% | 60,000 | Common | SOLE |
| 44486Q103 | HUMA | HUMACYTE INC | $730,850 | 0.41% | 235,000 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $684,775 | 0.38% | 32,500 | Common | SOLE |
| 89422GAA5 | TVTX 2.25 03/01/29 | TRAVERE THERAPEUTICS INC | $629,500 | 0.35% | 1,000,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $601,380 | 0.34% | 78,000 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $347,225 | 0.19% | 42,500 | Common | SOLE |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $263,783 | 0.15% | 340,761 | Common | SOLE |
| 55028X109 | 4NX1 | LUMOS PHARMA INC | $256,039 | 0.14% | 90,794 | Common | SOLE |
| 07134L107 | BATL | BATTALION OIL CORPORATION | $112,781 | 0.06% | 19,926 | Common | SOLE |
| 12122L119 | — | BURGERFI INTERNATIONAL INC | $81,254 | 0.05% | 2,083,438 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $58,943 | 0.03% | 75,000 | Common | SOLE |
| 594918104 | MSFT | MICROSOFT CORP | $42,072 | 0.02% | 100 | Common | SOLE |
| 02079K107 | GOOG | ALPHABET INC | $15,226 | 0.01% | 100 | Common | SOLE |
| 816850101 | SMTC | SEMTECH CORP | $385 | 0.00% | 14 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.